CURIOSITYSTREAM INC (CURI) Stock Fundamental Analysis
NASDAQ:CURI - Nasdaq - US23130Q1076 - Common Stock - Currency: USD
Taking everything into account, CURI scores 3 out of 10 in our fundamental rating. CURI was compared to 72 industry peers in the Entertainment industry. While CURI seems to be doing ok healthwise, there are quite some concerns on its profitability. CURI is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year CURI has reported negative net income.
CURI had a positive operating cash flow in the past year.
CURI had negative earnings in each of the past 5 years.
CURI had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
CURI's Return On Assets of -8.90% is on the low side compared to the rest of the industry. CURI is outperformed by 61.11% of its industry peers.
Looking at the Return On Equity, with a value of -13.05%, CURI is in line with its industry, outperforming 51.39% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.9% | ||
| ROE | -13.05% | ||
| ROIC | N/A |
ROA(3y)-32.15%
ROA(5y)-36.84%
ROE(3y)-44.33%
ROE(5y)-58.97%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CURI's Gross Margin of 52.61% is in line compared to the rest of the industry. CURI outperforms 58.33% of its industry peers.
In the last couple of years the Gross Margin of CURI has remained more or less at the same level.
CURI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 52.61% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.26%
GM growth 5YN/A
2. Health
2.1 Basic Checks
CURI does not have a ROIC to compare to the WACC, probably because it is not profitable.
CURI has more shares outstanding than it did 1 year ago.
CURI has more shares outstanding than it did 5 years ago.
There is no outstanding debt for CURI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
CURI has an Altman-Z score of 1.59. This is a bad value and indicates that CURI is not financially healthy and even has some risk of bankruptcy.
CURI has a Altman-Z score (1.59) which is comparable to the rest of the industry.
There is no outstanding debt for CURI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 1.59 |
ROIC/WACCN/A
WACC9.03%
2.3 Liquidity
A Current Ratio of 1.87 indicates that CURI should not have too much problems paying its short term obligations.
CURI has a better Current ratio (1.87) than 77.78% of its industry peers.
A Quick Ratio of 1.87 indicates that CURI should not have too much problems paying its short term obligations.
CURI's Quick ratio of 1.87 is fine compared to the rest of the industry. CURI outperforms 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.87 | ||
| Quick Ratio | 1.87 |
3. Growth
3.1 Past
CURI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 83.91%, which is quite impressive.
Looking at the last year, CURI shows a decrease in Revenue. The Revenue has decreased by -4.04% in the last year.
Measured over the past years, CURI shows a very negative growth in Revenue. The Revenue has been decreasing by -10.47% on average per year.
EPS 1Y (TTM)83.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.11%
Revenue 1Y (TTM)-4.04%
Revenue growth 3Y-10.47%
Revenue growth 5YN/A
Sales Q2Q%25.74%
3.2 Future
The Earnings Per Share is expected to grow by 50.40% on average over the next years. This is a very strong growth
Based on estimates for the next years, CURI will show a quite strong growth in Revenue. The Revenue will grow by 13.02% on average per year.
EPS Next Y72.37%
EPS Next 2Y39.15%
EPS Next 3Y35.9%
EPS Next 5Y50.4%
Revenue Next Year24.71%
Revenue Next 2Y18.63%
Revenue Next 3Y16.5%
Revenue Next 5Y13.02%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CURI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CURI. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CURI is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CURI indicates a somewhat cheap valuation: CURI is cheaper than 70.83% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29.71 | ||
| EV/EBITDA | 26.38 |
4.3 Compensation for Growth
A more expensive valuation may be justified as CURI's earnings are expected to grow with 35.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.15%
EPS Next 3Y35.9%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 5.34%, CURI is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.31, CURI pays a better dividend. On top of this CURI pays more dividend than 94.44% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, CURI pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.34% |
5.2 History
CURI does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
CURI has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-83.56%
EPS Next 2Y39.15%
EPS Next 3Y35.9%
4.81
+0.01 (+0.21%)
Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)
Earnings (Next)
Inst Owners12.78%
Inst Owner Change39.59%
Ins Owners7.55%
Ins Owner Change2.12%
Market Cap277.20M
Analysts86.67
Price Target4.69 (-2.49%)
Short Float %1.99%
Short Ratio0.81
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.34% |
Yearly Dividend0.07
Dividend Growth(5Y)N/A
DP-83.56%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)37.51%
Min EPS beat(2)-83.8%
Max EPS beat(2)158.81%
EPS beat(4)2
Avg EPS beat(4)6.81%
Min EPS beat(4)-83.8%
Max EPS beat(4)158.81%
EPS beat(8)3
Avg EPS beat(8)-23.16%
EPS beat(12)5
Avg EPS beat(12)-22.3%
EPS beat(16)9
Avg EPS beat(16)-6.16%
Revenue beat(2)1
Avg Revenue beat(2)1.88%
Min Revenue beat(2)-0.09%
Max Revenue beat(2)3.85%
Revenue beat(4)1
Avg Revenue beat(4)-2.02%
Min Revenue beat(4)-9.67%
Max Revenue beat(4)3.85%
Revenue beat(8)3
Avg Revenue beat(8)-0.9%
Revenue beat(12)6
Avg Revenue beat(12)-3.44%
Revenue beat(16)7
Avg Revenue beat(16)-3.33%
PT rev (1m)54.62%
PT rev (3m)67.27%
EPS NQ rev (1m)0%
EPS NQ rev (3m)25%
EPS NY rev (1m)0%
EPS NY rev (3m)7.14%
Revenue NQ rev (1m)-0.6%
Revenue NQ rev (3m)22.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)14.22%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 5.11 | ||
| P/FCF | 29.71 | ||
| P/OCF | 29.47 | ||
| P/B | 4.77 | ||
| P/tB | 9.8 | ||
| EV/EBITDA | 26.38 |
EPS(TTM)-0.14
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)0.16
FCFY3.37%
OCF(TTM)0.16
OCFY3.39%
SpS0.94
BVpS1.01
TBVpS0.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.9% | ||
| ROE | -13.05% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 52.61% | ||
| FCFM | 17.21% |
ROA(3y)-32.15%
ROA(5y)-36.84%
ROE(3y)-44.33%
ROE(5y)-58.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.26%
GM growth 5YN/A
F-Score6
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 0.44% | ||
| Cap/Sales | 0.14% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 113.37% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.87 | ||
| Quick Ratio | 1.87 | ||
| Altman-Z | 1.59 |
F-Score6
WACC9.03%
ROIC/WACCN/A
Cap/Depr(3y)0.12%
Cap/Depr(5y)1.04%
Cap/Sales(3y)0.06%
Cap/Sales(5y)0.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)83.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.11%
EPS Next Y72.37%
EPS Next 2Y39.15%
EPS Next 3Y35.9%
EPS Next 5Y50.4%
Revenue 1Y (TTM)-4.04%
Revenue growth 3Y-10.47%
Revenue growth 5YN/A
Sales Q2Q%25.74%
Revenue Next Year24.71%
Revenue Next 2Y18.63%
Revenue Next 3Y16.5%
Revenue Next 5Y13.02%
EBIT growth 1Y54.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year103.33%
EBIT Next 3Y51.16%
EBIT Next 5Y26.01%
FCF growth 1Y127.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y128.05%
OCF growth 3YN/A
OCF growth 5YN/A